[HTML][HTML] Less than 2% of the low-and intermediate-risk differentiated thyroid cancers show distant metastases at post-ablation whole-body scan
L Agate, F Bianchi, F Brozzi, P Santini… - European Thyroid …, 2019 - etj.bioscientifica.com
Background: Recently, there has been a trend to reduce the use of radioiodine remnant
ablation (RRA) in patients with low-risk (LR) and intermediate-risk (IR) differentiated thyroid …
ablation (RRA) in patients with low-risk (LR) and intermediate-risk (IR) differentiated thyroid …
Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer
Purpose The aim of our study was to compare the efficacy of thyroid remnant ablation using
low (1.1 GBq) and intermediate-high radioiodine (RAI) activity (1.85–3.7 GBq) in low-risk …
low (1.1 GBq) and intermediate-high radioiodine (RAI) activity (1.85–3.7 GBq) in low-risk …
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature
L Lamartina, C Durante, S Filetti… - The Journal of Clinical …, 2015 - academic.oup.com
Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence
PW Rosario, MS Furtado, AFCM Filho, RX Lacerda… - Thyroid, 2012 - liebertpub.com
Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …
Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation
Context: There is much debate surrounding the choice of which patient should be submitted
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
[HTML][HTML] Diagnostic whole-body scan may not be necessary for intermediate-risk patients with differentiated thyroid cancer after low-dose (30 mCi) radioactive iodide …
EJ Jeon, E Dal Jung - Endocrinology and Metabolism, 2014 - ncbi.nlm.nih.gov
Background A diagnostic whole-body scan (WBS) is recommended 6 to 12 months after total
thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …
thyroidectomy and radioactive iodide ablation in intermediate-or high-risk patients with …
[HTML][HTML] A prospective study showing an excellent response of patients with low-risk differentiated thyroid cancer who did not undergo radioiodine remnant ablation …
CCPS Janovsky, RMB Maciel… - European thyroid …, 2016 - etj.bioscientifica.com
Objectives: To prospectively evaluate the outcome of patients with low-risk papillary thyroid
carcinoma treated with total thyroidectomy (TT) who did not undergo radioiodine remnant …
carcinoma treated with total thyroidectomy (TT) who did not undergo radioiodine remnant …
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
A Piccardo, M Puntoni, G Ferrarazzo, L Foppiani… - European journal of …, 2018 - Springer
Purpose Current guidelines recommend thyroid hormone withdrawal (THW) of 3–4 weeks
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
[HTML][HTML] Is very high thyroid stimulating hormone level required in differentiated thyroid cancer for ablation success?
Z Hasbek, B Turgut - Molecular imaging and radionuclide therapy, 2016 - ncbi.nlm.nih.gov
Objective: Remnant ablation with radioactive iodine (I-131) is a successful form of treatment
that aims to destroy the remaining residual tissue and/or metastatic tissue after total …
that aims to destroy the remaining residual tissue and/or metastatic tissue after total …
Is there a role for diagnostic scans in the management of intermediate-risk thyroid cancer?
DLS Danilovic, GB Coura-Filho… - Endocrine-Related …, 2022 - erc.bioscientifica.com
Radioiodine (RAI) is selectively recommended for intermediate-risk differentiated thyroid
carcinomas (DTC). The information gleaned from pretherapy stimulated thyroglobulin levels …
carcinomas (DTC). The information gleaned from pretherapy stimulated thyroglobulin levels …